Serum AMH Levels in Patients Who Underwent Hypogastric Artery Ligation

AMH Clinical Trial

Official title:
Serum Antimullerian Hormone Levels in Patients Who Underwent Hypogastric Artery Ligation

Status Completed

Clinical Trial Summary

To observe the effects of hypogastric artery ligation on serum antimullerian hormone levels.

Clinical Trial Description

To measure and compare serum antimullerian hormone levels in patients who underwent hypogastric artery ligation/ hypogastric artery ligation+ hysterectomy and postpartum control. The procedures performed as an emergency life saving method during delivery. The reasons for hypogastric artery ligation/ hypogastric artery ligation+ hysterectomy were obstetric hemorrhage mainly uterine atony.

The serum levels of antimullerian hormone were measured 6 months after the operations and compared with matching postpartum controls. Serum levels of FSH, LH, PRL and TSH were also measured 6 months after the operation. Further, antral follicle count measured along with the aforementioned blood tests. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03220594
Study type	Observational [Patient Registry]
Source	Kanuni Sultan Suleyman Training and Research Hospital
Contact
Status	Completed
Phase	N/A
Start date	March 20, 2017
Completion date	September 29, 2017

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04512807` - AMH and Pregnancy Outcome in IVF
Recruiting	`NCT05592730` - AMHR2 Polymorphism in Blood and Granulosa Cells in Unexplained Infertility
Completed	`NCT04639505` - Predictive Value of New AMH Test Method for Ovarian Response
Not yet recruiting	`NCT06426771` - Effect of Antimullerian Hormone Levels on the Inflammatory Index, Phytochemical Index and NRF Nutrient Density
Recruiting	`NCT02785809` - Ovarian Function and Reserve Parameters After Discontinuation of Long-term Use of Oral Contraception	N/A
Recruiting	`NCT04927676` - Hormones in Hypogonadotropic Hypogonadism